Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review

BACKGROUND: From 2008–2013, the European indication for panitumumab required that patients’ tumor KRAS exon 2 mutation status was known prior to starting treatment. To evaluate physician awareness of panitumumab prescribing information and how physicians prescribe panitumumab in patients with metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Trojan, Jörg, Mineur, Laurent, Tomášek, Jiří, Rouleau, Etienne, Fabian, Pavel, de Maglio, Giovanna, García-Alfonso, Pilar, Aprile, Giuseppe, Taylor, Aliki, Kafatos, George, Downey, Gerald, Terwey, Jan-Henrik, van Krieken, J. Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619650/
https://www.ncbi.nlm.nih.gov/pubmed/26491871
http://dx.doi.org/10.1371/journal.pone.0140717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619650/
https://www.ncbi.nlm.nih.gov/pubmed/26491871
http://dx.doi.org/10.1371/journal.pone.0140717

Ejemplares similares